Martin D. Madaus (Millipore Corporation (NYSE: MIL))

Madaus, Martin D. (Quanterix 201107 Exec Chair + Acting CEO before Millipore CEO before Roche Diagnostics North America)

	Organisation	Millipore Corporation (NYSE: MIL)
	Today	Merck Millipore Division (EMD Millipore Division)
	Group	Merck (DE) (Group)
	Product	filter (laboratory/biochem production)
	Product 2	diagnostics (medical/biological)

Record changed: 2011-12-27

More documents for Martin D. Madaus

[1] Merck KGaA. (2/28/10). "Press Release: Merck KGaA and Millipore Announce Transaction. Merck to Acquire All Outstanding Millipore Shares for US$ 107 per Share in Cash, Creating a World-class Partner for the Life Science Sector". Darmstadt & Billerica, MA....
[2] Millipore Corporation. (2/2/10). "Press Release: Millipore Delivers Outstanding 2009 Financial Results. Company Delivers Double-digit Earnings Growth while Accelerating R&D Investments". Billerica, MA....
[3] Millipore Corporation. (12/15/09). "Press Release: Dr. Robert Langer Joins Millipore’s Board of Directors. Eminent MIT Scientist Brings Wealth of Expertise in Life Science Research Markets". Billerica, MA....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

Follow Us!

Top News

Upcoming Events

Associations

Partners

Martin D. Madaus (Millipore Corporation (NYSE: MIL))

More documents for Martin D. Madaus